|
Bakulin I.G., Abatsieva M. P., Skalinskaya M.I., Zhuravleva M.S.
Clinical and medico-social significance of NAFLD through the prism of comorbidity
|
№6 / 2019
|
|
Mazurov V.I., Petrova M.S., Gaydukova I.Z., Inamova O.V., Fonturenko A.Yu., Gaydukova E.K., Shapovalov A.A., Nagirnyak I.M.
Features of gouty arthritis according to the St. Petersburg City register of gout (2016–2018 years)
|
№6 / 2019
|
|
Mayorova M.V., Grigorieva N.Yu., Samolyuk M.O.
The role of endothelial dysfunction and oxidative stress in the formation of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease
|
№5 / 2019
|
|
Karoli N.A., Borodkin A.V., Rebrov A.P.
Peculiarities of chronic heart failure in COPD patients
|
№5 / 2019
|
|
Shulutko B.I., Makarenko S.V.
About comorbidity, entity of pathogenesis and optimization of internal diseases therapy
|
№1 / 2019
|
|
Ju.V. Lukina
Atherosclerosis and comorbidity
|
№4 / 2018
|
|
E.V. Nadei, V.I. Sovalkin, G.I. Nechaeva, D.V. Turchaninov
Feasibility of achieving control of comorbid atopic bronchial asthma
|
№3 / 2018
|
|
D.I. Trukhan, O.I. Lebedev, A.F. Sulimov, L.Yu. Trukhan
Change of the organ of vision, skin and mucosium shells in diseases of the intestine
|
№2 / 2018
|
|
Ye.I. Tarlovskaya
Problem of polymorbidity – challenge tо modern medicine
|
№2 / 2017
|
|
A.N. Kuznetsov, N.Yu. Grigorieva, T.P. Ilyushina, M.B. Mayorova
Is there a relationship between bronchial asthma and arterial hypertension?
|
№1 / 2017
|
|
T.V. Adasheva, A.G. Malyavin, A.I. Martynov
Expert support for medical decisions in rational use of medicines in the context of polymorbidity
|
№6 / 2016
|
|
M.Ye. Statsenko, S.V. Turkina, I.A. Tyshchenko, S.V. Fabritskaya
Application of Mildronate in patients with comorbidity: focus on cardioneurology
|
№5 / 2016
|
Русский
